Navigation Links
Takeda Announces Extension of FDA PDUFA Action Date for Vedolizumab for Ulcerative Colitis
Date:12/24/2013

DEERFIELD, Ill. and OSAKA, Japan, Dec. 24, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) Priority Review action date for the ulcerative colitis (UC) indication of Takeda's investigational biologic, vedolizumab. At the FDA's request, Takeda submitted a major amendment to its Biologics License Application (BLA) on December 6th which included updated proposed labeling. The FDA has now assigned a PDUFA action date of May 20, 2014 to allow the Agency time for a full review of the submission for the indication of the treatment of adults with moderately to severely active UC.   

Vedolizumab is also under review for the treatment of adults with moderately to severely active Crohn's disease (CD). The action date for the CD indication remains June 18, 2014. The BLA for vedolizumab was submitted in June 2013, and the FDA granted Priority Review status for the proposed indication in UC in September 2013 and standard review for the indication of CD.

"This short delay in the action date allows the FDA sufficient time to complete the review of the vedolizumab file and provide action on the application," said Tom Harris, head, global regulatory affairs, Takeda. "We appreciate the work of the FDA and remain confident in the potential of vedolizumab as an additional important treatment option for patients and the physicians who treat them for these serious conditions."

On December 9th, a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the FDA voted to recommend approval of Takeda's vedolizumab f
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Aug. 30, 2014   Royal Philips  (NYSE: PHG, ... a new ultrasound system designed to enable global ... increasing patient volumes and cost pressures. Making its debut ... in Barcelona this week, Affiniti ... patients with fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research ... Industry, 2009-2019 is a professional and in-depth market ... Scanner industry . The report firstly reviews the ... classification, application and manufacturing technology. The report then ... Crystallography Scanner listing their product specification, capacity, Production ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:9/1/2014)... honor of National Take Your Cat to the Vet Day, which ... Minnesota (AERC) is offering a few reasons why pet owners should ... don’t take their cat to the vet because “there’s nothing wrong” ... not to take their kid to dentist because he or she ... Just like people want their loved ones to be healthy, they ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
(Date:9/1/2014)... 2014 Registration is now open for the ... 1-Mile Race to be held on Sunday, September 21, 2014. ... at Harmon Meadow in Secaucus, New Jersey. All proceeds from ... nonprofit dedicated to restoring a sense of self, restoring the ... our military families. , General registration is $30 with special ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... Las Vegas, NV (PRWEB) September 01, 2014 ... for entrepreneurs and online marketers that was developed to ... campaign, has caught the attention of Shane Michaels, prompting ... even established entrepreneur, the daily duty of managing all ... online business can be quite overwhelming,” reports Michaels. “That’s ...
Breaking Medicine News(10 mins):Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
... -- The brains of people with autism concentrate more resources ... in areas used to plan and control thoughts and actions, ... people with autism have exceptional visual abilities, said the researchers ... 26 brain imaging studies that were conducted over 15 years ...
... Breast cancer risk can be assessed by examining ... preliminary study results presented at the AACR 102nd Annual ... method has the potential to provide a personalized assessment ... Arcaro, Ph.D., associate professor of veterinary and animal sciences ...
... Langone Medical Center have investigated a novel protein test ... accurately identify proteins secreted from cancerous tumors caused by ... Association for Cancer Research 102nd Annual Meeting 2011 on ... under the sponsorship of the National Cancer Institute,s Early ...
... , SUNDAY, April 3 (HealthDay News) -- New ... heart attack four years after the city was devastated ... Chronic stress, not being able to return home and ... situation, said the researchers, who updated their two-year post-Hurricane ...
... Health Study revealed that diabetes is associated with lower risk ... other cancers in both men and women. The data, to ... here April 2-6, also showed an association between diabetes and ... an association between diabetes and an increased risk for cancers ...
... SATURDAY, April 2 (HealthDay News) -- In a small preliminary ... number of episodes of a potentially dangerous irregular heartbeat known ... week also improved quality of life, lowering levels of the ... according to research to be presented Saturday at the annual ...
Cached Medicine News:Health News:Brains of People with Autism Focus More on Visual Skills 2Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:New test detects early-stage, asbestos-related pulmonary cancer 2Health News:Heart Attack Risk Plagues Post-Katrina New Orleans 2Health News:Avoiding or controlling diabetes may reduce cancer risk and mortality 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 2Health News:Yoga May Also Calm a Dangerous Irregular Heartbeat 3
... The Laserex Tango ophthalmic laser system provides ... SLT laser and a photodisruptor for posterior ... a frequency-doubled Nd:YAG producing pulsed 532 nm ... producing 1064 nm. The appropriate laser can ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Round handle....
5 mm concave jaws, cross action....
Medicine Products: